Basu Partha, Selmouni Farida, Belakhel Latifa, Sauvaget Catherine, Abousselham Loubna, Lucas Eric, Muwonge Richard, Sankaranarayanan Rengaswamy, Khazraji Youssef Chami
Screening Group, International Agency for Research on Cancer, Lyon, France.
Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Int J Cancer. 2018 Dec 15;143(12):3273-3280. doi: 10.1002/ijc.31749. Epub 2018 Sep 26.
Breast Cancer Screening Program was introduced and rolled out in Morocco in 2010. Women between 40 and 69 years are screened at the primary health centers (PHC) with clinical breast examination (CBE). A comprehensive evaluation of the program was conducted in 2016-2017 for quality assurance and mid-term course correction. The evaluation process involved: in-depth interviews of program managers; focus group discussions with service-providers of screening, diagnosis and treatment; supportive supervisory visits to randomly selected PHCs and diagnostic centers; desk review of the national guidelines and other published documents; and analysis of the performance data compiled by the program-in-charge. We found that the program has strong political support, a well-organized management structure and documented national policy and protocol. In absence of a mechanism to identify and invite the eligible women individually, the program is opportunistic in nature. Every PHC is provided with an annual target to be screened. A highly visible annual campaign to educate and motivate women has a major impact on participation. Record keeping and data collection are paper-based. In the years 2015 and 2016, 1.1 and 1.5 million women were screened, respectively. In the year 2015, 62.8% of the annual target population was covered, CBE positivity was 3.2%, a further assessment rate of screen-positive women was 34.1% and the breast cancer detection rate was 1.0/1000 women. Systematic paper-based data collection enabled the assessment of some of the process and outcome indicators. The screening coverage was moderate and the cancer detection rate was low.
乳腺癌筛查项目于2010年在摩洛哥推出并实施。40至69岁的女性在初级卫生保健中心(PHC)接受临床乳房检查(CBE)。2016 - 2017年对该项目进行了全面评估,以确保质量并进行中期调整。评估过程包括:对项目管理人员进行深入访谈;与筛查、诊断和治疗服务提供者进行焦点小组讨论;对随机选择的初级卫生保健中心和诊断中心进行支持性监督访问;对国家指南和其他已发表文件进行案头审查;以及分析项目负责人汇编的绩效数据。我们发现该项目有强有力的政治支持、组织良好的管理结构以及成文的国家政策和方案。由于缺乏识别和单独邀请符合条件女性的机制,该项目本质上具有机会主义性质。每个初级卫生保健中心都有年度筛查目标。一场备受瞩目的年度宣传活动,旨在教育和激励女性,对参与率有重大影响。记录保存和数据收集以纸质形式进行。2015年和2016年分别有110万和150万女性接受了筛查。2015年,覆盖了年度目标人群的62.8%,CBE阳性率为3.2%,筛查呈阳性女性的进一步评估率为34.1%,乳腺癌检出率为每1000名女性中有1.0例。基于纸质的系统数据收集使得能够评估一些过程和结果指标。筛查覆盖率中等,癌症检出率较低。